fenofibrate has been researched along with Endometrial Neoplasms in 2 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
Endometrial Neoplasms: Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A nude mouse model of endometrial carcinoma was used to investigate the effect of fenofibrate in vivo but failed to show consistent inhibition of tumour growth." | 1.33 | In vitro and in vivo effects of the PPAR-alpha agonists fenofibrate and retinoic acid in endometrial cancer. ( Charnock-Jones, DS; Holland, CM; Saidi, SA; Smith, SK, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miao, C | 1 |
| Chen, Y | 1 |
| Fang, X | 1 |
| Zhao, Y | 1 |
| Wang, R | 1 |
| Zhang, Q | 1 |
| Saidi, SA | 1 |
| Holland, CM | 1 |
| Charnock-Jones, DS | 1 |
| Smith, SK | 1 |
2 other studies available for fenofibrate and Endometrial Neoplasms
| Article | Year |
|---|---|
Identification of the shared gene signatures and pathways between polycystic ovary syndrome and endometrial cancer: An omics data based combined approach.
Topics: Computational Biology; Endometrial Neoplasms; Female; Fenofibrate; Gene Regulatory Networks; Humans; | 2022 |
In vitro and in vivo effects of the PPAR-alpha agonists fenofibrate and retinoic acid in endometrial cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Dose-Res | 2006 |